Singapore biotech start-up Mirxes to join Hang Seng Composite Index 3 months after Hong Kong IPO

Sign up now: Get ST’s newsletters delivered to your inbox

Mirxes will be one of 17 biotech stocks on the index.

SINGAPORE – Local firm Mirxes will be added to Hong Kong’s Hang Seng Composite Index (HSCI) on Sept 8, a move expected to boost its visibility and trading liquidity, and marking a rare win for a Singapore biotech company on the global stage.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.